Shanghai Fosun Pharmaceutical Gro.../ CNE000000X38 /
2024-04-19 9:00:00 AM | Chg. -0.26 | Volume | Bid2024-04-19 | Ask9:00:02 AM | High | Low |
---|---|---|---|---|---|---|
22.51CNY | -1.14% | 5.89 mill. Turnover: 133.06 mill. |
22.51Bid Size: 54,256 | 22.52Ask Size: 7,600 | 22.81 | 22.45 |
GlobeNewswire
2021-10-22
Genetron Health and Fosun Pharma Announce Exclusive Partnership to Commercialize Seq-MRD® in China
GlobeNewswire
2021-10-12
Helsinn and Fosun Pharma sign exclusive license and distribution agreements for Aloxi®, Akynzeo® ora...
GlobeNewswire
2021-01-13
Rockwell Medical Announces Dosing of First Patient in Pivotal Triferic® Phase 3 Trial by Partner, Wa...
GlobeNewswire
2021-01-07
Dräger Extends Ventilation Solutions Into U.S. Long-Term Care Facilities Through Breas Medical Distr...
GlobeNewswire
2020-09-29
Polyphor Announces Closing of Fosun Pharma Licensing Agreement for balixafortide in China and Receip...